The International Diabetes Federation's Life for a Child Programme currently supports the care of 4000 children in 26 countries worldwide. The programme meets the children's immediate needs (insulin, syringes, monitoring and education), builds local capacity and lobbies governments to establish sustainable solutions. Eli Lilly is the main provider of insulin for this program.

ISPAD is a sponsor of this program and has pledged structural support and assistance in the training of pediatricians and healthcare professionals in childhood and adolescent diabetes through its membership network. Please contact the ISPAD steering committee or Graham Ogle (see ISPAD membership directory for contact details) from Life for a Child if you are interested in helping with such issues.